
The START Center for Cancer Research is partnering with Rome-based Istituti Fisioterapici Ospitalieri (IFO) to establish an early-phase oncology clinical …

Diagnostic innovation and patient safety have dominated this yearโs healthcare-focussed awards to mark European Laboratory Day. Staged by the European …

Breast Cancer Now is investing ยฃ800,000 in two research projects using artificial intelligence to investigate why oestrogen receptor-positive (ER-positive) breast …

Most patients with advanced hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer are treated in community settings rather than academic centres, potentially …

Bristol Myers Squibb (BMS) has announced that its Opdivo (nivolumab) has been accepted, in combination with Yervoy (ipilimumab), by the …

Astellas Pharma, a pharmaceutical company creating medicines to address unmet medical needs, has announced that Vyloy (zolbetuximab), in combination with …

For decades, oncology trials have been anchored to a familiar set of endpoints. Overall survival (OS) and progression-free survival (PFS) …

Pharma& has announced that its treatment for ovarian cancer, Rubraca (rucaparib), has been accepted by the Scottish Medicines Consortium (SMC) …

The agreement expands access to oncology testing kits across Europe

Breast cancer remains one of the leading health threats to women over 35 in the UK Micrima, a healthcare technology …

Pharmafile talks to Emma Roffe, Oncology Country Head (UK & Ireland) about the combination treatment landscape and the impact of …

BioMed X and Servier have announced the launch of Europeโs first XSeed Labs research project, located at the Spartners incubator …

ANGLE has announced three new peer-reviewed publications demonstrating the use of its Parsortix circulating tumour cell (CTC) harvesting system in …

BioNTech and Bristol Myers Squibb (BMS) have entered a partnership to collaboratively develop and commercialise BNT327, BioNTechโs bispecific antibody, to …

Ryvu Therapeutics has promoted Justyna ลปรณลtek, chief people officer, to its management board. The appointment reflects the companyโs focus on …